Dicky J. Kortleve-Lindenbergh

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Epithelial SLPI expression in severe inflammatory bowel disease relates to high IL-17 and neutrophil programming.

Epithelial SLPI expression in severe inflammatory bowel disease relates to high IL-17 and neutrophil programming.

Journal: JCI insight

Published: June 23, 2025

Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.

Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.

Journal: European journal of immunology

Published: April 24, 2022

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.

Journal: Scientific reports

Published: March 31, 2022

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.

Journal: Oncoimmunology

Published: October 26, 2020

Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis.

Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis.

Journal: Mucosal immunology

Published: November 13, 2019

IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease.

IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4+ T cells: relevance to inflammatory bowel disease.

Journal: Mucosal immunology

Published: July 27, 2018

Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.

Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.

Journal: Leukemia

Published: March 22, 2018

IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine.

IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine.

Journal: Mucosal immunology

Published: March 15, 2018

Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.

Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor.

Journal: Journal of pediatric gastroenterology and nutrition

Published: June 24, 2017

TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine.

TGFβR signalling controls CD103+CD11b+ dendritic cell development in the intestine.

Journal: Nature communications

Published: December 12, 2016

Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants.

Human Intestinal PEPT1 Transporter Expression and Localization in Preterm and Term Infants.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: December 04, 2015

IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine.

IL-10 control of CD11c+ myeloid cells is essential to maintain immune homeostasis in the small and large intestine.

Journal: Oncotarget

Published: July 16, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026